Department of Radiation Oncology, University of Utah Health Sciences and Huntsman Cancer Institute, Salt Lake City, UT, USA.
Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):333-8. doi: 10.1016/j.ijrobp.2010.01.058. Epub 2010 Jun 18.
Postoperative radiation therapy (RT) is recommended for patients with rhabdomyosarcoma having microscopic disease. Sometimes RT dose/volume is reduced or omitted in an attempt to avoid late effects, particularly in young children. We reviewed operative bed recurrences to determine if noncompliance with RT protocol guidelines influenced local-regional control.
All operative bed recurrences among 695 Group II rhabdomyosarcoma patients in Intergroup Rhabdomyosarcoma Study Group (IRS) I through IV were reviewed for deviation from RT protocol. Major/minor dose deviation was defined as >10% or 6-10% of the prescribed dose (40-60 Gy), respectively. Major/minor volume deviation was defined as tumor excluded from the RT field or treatment volume not covered by the specified margin (preoperative tumor volume and 2- to 5-cm margin), respectively. No RT was a major deviation.
Forty-six of 83 (55%) patients with operative bed recurrences did not receive the intended RT (39 major and 7 minor deviations). RT omission was the most frequent RT protocol deviation (19/46, 41%), followed by dose (17/46, 37%), volume (9/46, 20%), and dose and volume deviation (1/46, 2%). Only 7 operative bed recurrences occurred in IRS IV (5% local-regional failure) with only 3 RT protocol deviations. Sixty-three (76%) patients with recurrence died of disease despite retrieval therapy, including 13 of 19 nonirradiated children.
Over half of the operative bed recurrences were associated with noncompliance; omission of RT was the most common protocol deviation. Three fourths of children die when local-regional disease is not controlled, emphasizing the importance of RT in Group II rhabdomyosarcoma.
对于患有横纹肌肉瘤且存在显微镜下疾病的患者,建议进行术后放疗(RT)。有时,为了避免晚期效应,特别是在年幼的儿童中,会降低或省略 RT 剂量/体积。我们回顾了手术床复发的情况,以确定是否不遵守 RT 方案指南会影响局部区域控制。
对 Intergroup Rhabdomyosarcoma Study Group(IRS)I-IV 中 695 例 II 期横纹肌肉瘤患者的所有手术床复发情况进行了回顾,以确定是否存在 RT 方案偏离。主要/次要剂量偏离定义为超过规定剂量(40-60Gy)的 10%或 6-10%;主要/次要体积偏离定义为肿瘤被排除在 RT 野之外或治疗体积未覆盖规定边界(术前肿瘤体积和 2-5cm 边界)。未接受 RT 为主要偏离。
46 例手术床复发患者(55%)未接受预期的 RT(39 例主要偏离和 7 例次要偏离)。RT 遗漏是最常见的 RT 方案偏离(19/46,41%),其次是剂量(17/46,37%)、体积(9/46,20%)和剂量和体积偏离(1/46,2%)。只有 7 例手术床复发发生在 IRS IV(5%的局部区域失败),仅有 3 例 RT 方案偏离。尽管进行了检索治疗,但仍有 63 例(76%)复发患者死于疾病,其中包括 19 名未接受放疗的儿童中的 13 名。
超过一半的手术床复发与不遵守方案有关;RT 遗漏是最常见的方案偏离。当局部区域疾病未得到控制时,四分之三的儿童死亡,这强调了 RT 在 II 期横纹肌肉瘤中的重要性。